Bronchodilator responsiveness in children with asthma is not influenced by spacer device selection
Pediatric Pulmonology2019Vol. 54(5), pp. 531–536
Citations Over Time
Abstract
Spacer device was not associated with clinically important differences in lung function following bronchodilator inhalation in children with asthma. At a recommended dose of 400 μg, some children with asthma may have their bronchodilator responsiveness misclassified.
Related Papers
- → Evaluation of Interpretation Strategies and Substantial Bronchodilator Response in Pediatric Patients With Normal Baseline Spirometry(2012)2 cited
- → Effect of acute hyperoxia on the bronchodilator response to salbutamol in stable asthmatic patients.(1996)6 cited
- → The Bronchodilator Effect of Salbutamol Administered by IPPB to Patients with Asthma(1972)7 cited
- → Three 20‐Minute Interspaced Salbutamol Inhalations as a Test for the Diagnosis of Reversible Airflow Limitation in Adult Asthmatics(2004)2 cited
- [Comparative therapeutic effect of bronchodilator aerosols and salbutamol cyclocaps].(1994)